Globe Life reports mixed Q3 results and raises 2026 share-repurchase outlook

Globe Life reported third-quarter 2026 net income of $4.62 per diluted share, down from $4.73 a year earlier, while net operating income rose to $4.84 per share from $4.81; total premium revenue increased 7% to $1.31 billion. The company lowered its 2026 earnings guidance to $15.35-$15.65 per share because of high-severity claims at Evry and excess Medicare Supplement claims tied to a Centers for Medicare and Medicaid Services processing delay, while projecting 2027 net operating income of $16.10-$17.10 per share. Globe Life repurchased 1.1 million shares for $185 million in the quarter and now expects full-year 2026 repurchases of $725 million-$775 million.